Kwality Pharmaceuticals P/B Ratio
Kwality Pharmaceuticals (KPL) P/B ratio is 7.0 (High), book value per share ₹332.00 vs Healthcare average P/B of -0.33 — Very High - Significant premium, high growth expectations or speculative. For live price, earnings yield and the full fundamental profile, see KPL share price screener.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
KPL P/B Ratio — Valuation Insights & Book Value Analysis
Kwality Pharmaceuticals price-to-book ratio interpretation, valuation status and historical context — current P/B 7.0 (High). Compare with Kwality Pharmaceuticals valuation methods to assess whether the stock is under or overvalued.
- Stock appears overvalued with PB of 7.0, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 84.4% above historical average
- Trading at premium to sector average PB of -0.33
Kwality Pharmaceuticals P/B Ratio Historical Trend
KPL annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. View KPL annual price range for the annual high/low range and current price position.
KPL Historical P/B Ratio — Book Value Per Share & Year-End Price
Kwality Pharmaceuticals annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 6.74 | ₹332.0 | ₹2236.80 | ₹332 | High |
| 2025 | 4.23 | ₹262.0 | ₹1108.35 | ₹262 | High |
| 2024 | 3.89 | ₹223.0 | ₹866.80 | ₹223 | High |
| 2023 | 2.01 | ₹199.0 | ₹399.80 | ₹199 | Moderate |
| 2022 | 2.11 | ₹180.0 | ₹379.80 | ₹180 | Moderate |
KPL vs Healthcare Peers — P/B Ratio Comparison
Kwality Pharmaceuticals P/B 7.0 vs Healthcare average -0.33, median 0.63 — range -17.92–1.01.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -17.92 | ₹22 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Parmax Pharma | PARMAX | -2.48 | ₹14 | Low |
| Bharat Immunologicals | BIBCL | -2.32 | ₹76 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.71 | ₹127 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.63 | ₹53 | Low |